During the past decade, Psychiatricka nemocnica Michalovce, n.o. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Psychiatricka nemocnica Michalovce, n.o." are "Alzheimer Disease" (2 trials), "Schizophrenia" (2 trials), "Alzheimer's Disease" (1 trials), "Mental Illness" (1 trials) and "Stigmatization" (1 trials). Many other conditions were trialed in "Psychiatricka nemocnica Michalovce, n.o." in a lesser frequency.

Most popular intervention types in "Psychiatricka nemocnica Michalovce, n.o." are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lurasidone" (2 trials), "bapineuzumab" (2 trials), "placebo" (2 trials), "Lurasidone 80 mg once daily initially rerandomized either to 80 mg or 160 mg at week 2" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Psychiatricka nemocnica Michalovce, n.o." are 6 trials for "All" genders.

Currently, there are NaN active trials in "Psychiatricka nemocnica Michalovce, n.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Psychiatricka nemocnica Michalovce, n.o., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Psychiatricka nemocnica Michalovce, n.o., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".